INFECTIOUS DISEASES / Virology
Research Interests
Arboviral pathogenesis, vector biology, virus-host interactions, virology, Molecular epidemiology, Emerging infectious diseases.

Description of Research
The Vector Borne Diseases (VBD) Group, led by Dr. Sujatha Sunil, investigates the molecular, viral, vector, and epidemiological mechanisms that underpin arboviral infections, with primary focus on chikungunya and dengue viruses. The group seeks to understand how viruses interact with both their hosts and vectors to establish infection, evade immune defenses, and drive outbreaks.
At the molecular level, the team studies virus–host interactions, identifying viral and cellular factors that modulate replication, immune suppression, and chronic disease progression. Using approaches in molecular virology, functional genomics, proteomics, and reverse genetics, the laboratory has uncovered host regulatory networks and viral RNA-interference suppressors that define pathogenesis and persistence.
Complementing this, the VBD Group conducts extensive vector biology studies to characterize Aedes mosquito populations across India, assessing their competence, genetic diversity, and role in virus maintenance, including evidence for natural vertical transmission. These studies bridge laboratory and field biology to clarify how mosquito physiology and genetics influence viral transmission efficiency.
The group also integrates molecular epidemiology and climate analysis to examine how environmental factors—such as temperature, rainfall, and humidity—affect mosquito abundance, virus evolution, and disease dynamics. By linking laboratory findings with climatic data, the team aims to develop early-warning models for predicting arboviral outbreaks under changing climate conditions.
Through this multidisciplinary framework, Dr. Sunil’s group advances a systems-level understanding of arboviral pathogenesis, vector competence, and outbreak ecology, translating fundamental discoveries into strategies that strengthen surveillance and preparedness for emerging vector-borne diseases.

Recent publications
Srivastava P, Mishra N, Dubey SK, Shrinet J, Chaudhary S, Kumar R, Kumar A, Malhotra S, Mano M, Braga L, Varma B, Giacca M, Sunil S. Dual Regulatory Role of hsa-miR-122b-5p in Chikungunya Virus Infection via Interaction with CHIKV 3′-UTR and HDAC4 Modulation. J Virol. 2025. https://doi.org/10.1128/jvi.02118-24.
Hasan A, Sharma G, Majumder N, Chaudhary S, Mehta D, Vaishya R, Ghosh S and Sunil S. Global proteome analysis of a three-dimensional human chondrocyte cell culture system infected with chikungunya virus (CHIKV) reveals distinct immune and inflammatory signatures. ACS Omega. 2025. DOI: 10.1021/acsomega.5c02832.
Mishra N1,2, Chaudhary Y1#, Chaudhary S1, Singh A1, Sunil S*1. Proteomic Analysis of CHIKV nsP3-Host Interactions in Liver Cells Identifies Novel Interacting Partners. Int. J. Mol. Sci. 2025. 26(14), 6832; https://doi.org/10.3390/ijms26146832
Babu N, Jayaram A, Shetty U, Varamballi P, Mudgal PP, Suri V, Singh MP, Kamaljeet, Agrawal S, Kaneria M, Kini S, Dey A, Das DS, Mahilkar S, Mathur G, Kumar SP, Singh S, Pani SS, Chattopadhyay S, Sunil S, Mishra B, Shastri JS, Ratho RK, Jagadesh A. Clinical epidemiology of chikungunya outbreaks in India between 2019 – 2022. Scientific Reports. (2025) 15:27280
Verma DK, Chaudhary S, Sunil S. Investigation of endocytic pathways during entry of RNA viruses revealed novel host proteins as lipid raft dependent endocytosis mediators. 2025. Virology. 608, 110531.
Mathur G, Mahilkar S and Sunil S. Generation and characterization of infectious clones of chikungunya virus from an Indian strain as a resource towards chikungunya vaccine research. 2025. Virus Research. 356, 199571.



